Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Paratek Pharmaceuticals Stockholders To Receive Upfront Cash Payment Of $2.15 Per Share And A Contingent Value Right Of $0.85 Per Share On Achievement Of A Commercial Milestone For A Total Potential Value Of $3.00 Per Share

Author: Happy Mohamed | August 02, 2023 05:41pm

Posted In: PRTK